Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Participation in the Food and Drug Administration Commissioner's Fellowship Program, 64805-64806 [2014-25893]
Download as PDF
Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices
size, use this information to deduce the
identity of a particular individual).
may make searching for a record easier
and prevent delay).
RETENTION AND DISPOSAL:
RECORD ACCESS PROCEDURE:
CMS will retain information for a total
period not to exceed 30 years. All
claims-related records are encompassed
by the document preservation order and
will be retained until notification is
received from DOJ.
An individual seeking access to
records about him or her in this system
should use the same procedures
outlined in Notification Procedures
above. The requestor should also
reasonably specify the record contents
being sought. (These procedures are in
accordance with Department regulation
45 CFR 5b.5(a)(2).)
RETRIEVING, ACCESSING, RETAINING, AND
DISPOSING OF RECORDS IN THE SYSTEM:
STORAGE:
CONTESTING RECORD PROCEDURES:
All records are stored on electronic
media.
RETRIEVABILITY:
The collected data are retrieved by an
individual identifier; e.g., beneficiary,
recipient or provider name, HICN, or
unique provider identification number
(NPI).
SAFEGUARDS:
CMS has safeguards in place for
authorized users and monitors such
users to ensure against excessive or
unauthorized use. Personnel having
access to the system have been trained
in the Privacy Act and information
security requirements. Employees who
maintain records in this system are
instructed not to release data until the
intended recipient agrees to implement
appropriate management, operational
and technical safeguards sufficient to
protect the confidentiality, integrity and
availability of the information and
information systems and to prevent
unauthorized access.
This system will conform to all
applicable Federal laws and regulations
and Federal, HHS, and CMS policies
and standards as they relate to
information security and data privacy.
These laws and regulations may apply
but are not limited to: The Privacy Act
of 1974; and the Federal Information
Department regulation 45 CFR 5b.7.
SYSTEM MANAGER AND ADDRESS:
Director, Data Development and
Services Group, Office of Information
Products and Data Analytics (OIPDA),
OEM, Mail Stop B2–29–04, CMS, 7500
Security Boulevard, Baltimore, MD
21244–1849.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
NOTIFICATION PROCEDURE:
An individual record subject who
wishes to know if this system contains
records about him or her should write
to the system manager who will require
the system name, HICN, and for
verification purposes, the subject
individual’s name (woman’s maiden
name, if applicable), and SSN
(furnishing the SSN is voluntary, but it
VerDate Sep<11>2014
18:51 Oct 30, 2014
Jkt 235001
To contest a record, the subject
individual should contact the system
manager named above, and reasonably
identify the record and specify the
information to be contested. The
individual should state the corrective
action sought and the reasons for the
correction with supporting justification.
(These procedures are in accordance
with Department regulation 45 CFR
5b.7.)
RECORDS SOURCE CATEGORIES:
Frm 00065
Fmt 4703
Sfmt 4703
and Assessment Information Set,
System No. 09–70–0522 (72 FR 63906
(November 13, 2007)); and Integrated
Data Repository, System No. 09–70–
0571 (71 FR 74915 (December 13,
2006)); Provider Enrollment Chain and
Ownership System, System No. 09–70–
0532 (71 FR 60536 (October 13, 2006);
Medicare and Medicaid Electronic
Health Record (EHR) Incentive Program
National Level Repository, System No.
09–70–0587 (75 FR 73095 (November
29, 2010)); Performance Measurement
and Reporting System, System No. 09–
70–0584 (74 FR 17672 (April 16, 2009));
Encounter Data System, 09–70–0506 (79
FR 34539 (June 17, 2014)); and National
Death Index, 09–20–0166 (49 FR 37692
(September 25, 1984)).
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS
OF THE ACT:
None.
Celeste Dade-Vinson,
Health Insurance Specialist, Centers for
Medicare & Medicaid Services.
[FR Doc. 2014–25937 Filed 10–30–14; 8:45 am]
The data collected and maintained in
this system are retrieved from the
following databases: Medicare Drug
Data Processing System, System No. 09–
70–0553 (73 FR 30943 (May 29, 2008));
Medicare Beneficiary Database, System
No. 09–70–0536 (71 FR 70396
(December 4, 2006)); Medicare
Advantage Prescription Drug System,
System No. 09–70–0588 (76 FR 47190
(August 4, 2011)); Medicaid Statistical
Information System, System No. 09–70–
0541 (71 FR 65527 (November 8, 2006));
Retiree Drug Subsidy Program, System
No. 09–70–0550 (70 FR 41035 (July 15,
2005)); Common Working File, System
No. 09–70–0526 (71 FR 64955
(November 6, 2006)); National Claims
History, System No. 09–70–0558 (71 FR
67137 11/20/2006 (November 20,
2006)); Enrollment Database, System
No. 09–70–0502 (73 FR 10249 2/26/
2008 (February 26, 2008)); Carrier
Medicare Claims Record, System No.
09–70–0501 (71 FR 64968 11/6/2006
(November 6, 2006)); Intermediary
Medicare Claims Record, System No.
09–70–0503 (71 FR 648961 (November
6, 2006)); Unique Physician/Provider
Identification Number, System No. 09–
70–0525 (71 FR 66535 (November 15,
2006)); Medicare Supplier Identification
File, System No. 09–70–0530 (71 FR
70404 (December 4, 2006)), A Current
Beneficiary Survey, System No. 09–70–
0519 (71 FR 60722 (October 16, 2006));
National Plan & Provider Enumerator
System, System No. 09–70–0555, (75 FR
30411 (June 1, 2010)); Long Term Care
MDS, System No. 09–70–0528 (72 FR
12801 (March 19, 2007)); HHA Outcome
PO 00000
64805
BILLING CODE 4120–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1072]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Application for
Participation in the Food and Drug
Administration Commissioner’s
Fellowship Program
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by December
1, 2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910—New and
SUMMARY:
E:\FR\FM\31OCN1.SGM
31OCN1
64806
Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices
title ‘‘Application for Participation in
the Food and Drug Administration
Commissioner’s Fellowship Program.’’
Also include the FDA docket number
found in brackets in the heading of this
document.
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Application for Participation in the
FDA Commissioner’s Fellowship
Program; (OMB Control Number 0910—
New)
Sections 1104, 1302, 3301, 3304,
3320, 3361, 3393, and 3394 of Title 5 of
the United States Code authorize
Federal Agencies to rate applicants for
Federal jobs. Collecting applications for
the Commissioner’s Fellowship Program
will allow FDA’s Office of the
Commissioner to easily and efficiently
elicit and review information from
students and health care professionals
who are interested in becoming
involved in FDA-wide activities. The
process will reduce the time and cost of
submitting written documentation to the
Agency and lessen the likelihood of
applications being misrouted within the
Agency mail system. It will assist the
Agency in promoting and protecting the
public health by encouraging outside
persons to share their expertise with
FDA.
In the Federal Register of August 4,
2014 (79 FR 45196), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. Although one comment
was received, it was not responsive to
the four collection of information topics
solicited and, therefore, will not be
discussed in this document.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity/5 U.S.C. section
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 .......
600
1
600
1.33
798
Total ..............................................................................
........................
........................
........................
........................
798
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA based these estimates on the
number of inquiries that have been
received concerning the program and
the number of requests for application
forms over the past 5 years.
Dated: October 27, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–25893 Filed 10–30–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0801]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Exports:
Notification and Recordkeeping
Requirements; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
document announced that a proposed
collection of information had been
submitted to the Office of Management
and Budget (OMB) for review and
clearance under the Paperwork
Reduction Act of 1995. In this
document, we correct some errors that
appeared in the notice.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
In FR Doc.
2014–24293, appearing on page 61643
in the Federal Register of October 14,
2014 (79 FR 61643), we make the
following correction: On page 61644,
replace table 1 with the following table:
SUPPLEMENTARY INFORMATION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of October 14, 2014. The
SUMMARY:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
asabaliauskas on DSK5VPTVN1PROD with NOTICES
21 CFR section
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
1.101(d) (Non-Tobacco) (CBER) .........................................
1,101(d) (Non-Tobacco) (CDER) .........................................
1.101(d) (Non-Tobacco) (CDRH) .........................................
5
5
63
193
180
130
965
900
8,190
15
15
15
14,475
13,500
122,850
Total 2 ............................................................................
........................
........................
........................
........................
150,825
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
to a clerical error, the reporting burden for ‘‘Exports: Notification and Recordkeeping Requirements’’, which published on July 3, 2014 (79
FR 38036), was incorrect. Table 1 of this document contains the correct reporting burden for this collection.
2 Due
VerDate Sep<11>2014
20:52 Oct 30, 2014
Jkt 235001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
E:\FR\FM\31OCN1.SGM
31OCN1
Agencies
[Federal Register Volume 79, Number 211 (Friday, October 31, 2014)]
[Notices]
[Pages 64805-64806]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-25893]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1072]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Application for
Participation in the Food and Drug Administration Commissioner's
Fellowship Program
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
December 1, 2014.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910--New and
[[Page 64806]]
title ``Application for Participation in the Food and Drug
Administration Commissioner's Fellowship Program.'' Also include the
FDA docket number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Application for Participation in the FDA Commissioner's Fellowship
Program; (OMB Control Number 0910--New)
Sections 1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 of
Title 5 of the United States Code authorize Federal Agencies to rate
applicants for Federal jobs. Collecting applications for the
Commissioner's Fellowship Program will allow FDA's Office of the
Commissioner to easily and efficiently elicit and review information
from students and health care professionals who are interested in
becoming involved in FDA-wide activities. The process will reduce the
time and cost of submitting written documentation to the Agency and
lessen the likelihood of applications being misrouted within the Agency
mail system. It will assist the Agency in promoting and protecting the
public health by encouraging outside persons to share their expertise
with FDA.
In the Federal Register of August 4, 2014 (79 FR 45196), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. Although one comment was received, it was
not responsive to the four collection of information topics solicited
and, therefore, will not be discussed in this document.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Average
Activity/5 U.S.C. section Number of responses per Total annual burden per Total hours
respondents respondent responses response
----------------------------------------------------------------------------------------------------------------
1104, 1302, 3301, 3304, 3320, 600 1 600 1.33 798
3361, 3393, and 3394...........
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 798
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
FDA based these estimates on the number of inquiries that have been
received concerning the program and the number of requests for
application forms over the past 5 years.
Dated: October 27, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-25893 Filed 10-30-14; 8:45 am]
BILLING CODE 4164-01-P